Cardioprotective Drug Prevents Severe Cardiac Events in Children Undergoing Chemotherapy for Acute Myeloid Leukemia
Apr 28, 2020
CHOP researchers found the use of dexrazoxane throughout AML treatment had a significantly lower risk of developing cardiac complications.